Adial Pharmaceuticals WT Price Prediction
ADILWDelisted Stock | USD 0.01 0 52.50% |
Oversold Vs Overbought
42
Oversold | Overbought |
Using Adial Pharmaceuticals hype-based prediction, you can estimate the value of Adial Pharmaceuticals WT from the perspective of Adial Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Adial Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Adial because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Adial Pharmaceuticals after-hype prediction price | USD 0.008296 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Adial |
Adial Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Adial Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Adial Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Adial Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
Adial Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Adial Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Adial Pharmaceuticals' historical news coverage. Adial Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.01 and 0.01, respectively. We have considered Adial Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Adial Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Adial Pharmaceuticals is based on 3 months time horizon.
Adial Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Adial Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Adial Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Adial Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 1 Events / Month | 1 Events / Month | Very soon |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.01 | 0.01 | 36.00 |
|
Adial Pharmaceuticals Hype Timeline
Adial Pharmaceuticals is presently traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Adial is expected to increase in value after the next headline, with the price projected to jump to 0.008296 or above. The average volatility of media hype impact on the company the price is insignificant. The price increase on the next news is projected to be 36.0%, whereas the daily expected return is presently at 0.0%. The volatility of related hype on Adial Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.01. Adial Pharmaceuticals WT has accumulated 207.38 K in total debt. Note, when we think about Adial Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.Assuming the 90 days horizon the next expected press release will be very soon. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.Adial Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Adial Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Adial Pharmaceuticals' future price movements. Getting to know how Adial Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Adial Pharmaceuticals may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
ENTXW | Entera Bio | 0.0008 | 2 per month | 30.23 | 0.13 | 135.48 | (57.53) | 266.82 | |
ARTLW | Artelo Biosciences | 0.00 | 0 per month | 23.45 | 0.08 | 68.38 | (41.25) | 147.53 | |
IMACW | IMAC Holdings | 0.00 | 3 per month | 26.50 | 0.17 | 166.67 | (69.50) | 707.09 | |
CREXW | Creative Realities WT | 0.00 | 1 per month | 27.59 | 0.16 | 135.71 | (56.85) | 370.19 | |
BCDAW | BioCardia | (0.0002) | 1 per month | 18.27 | 0.06 | 57.25 | (40.00) | 139.50 |
Adial Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Adial price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Adial using various technical indicators. When you analyze Adial charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Adial Pharmaceuticals Predictive Indicators
The successful prediction of Adial Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Adial Pharmaceuticals WT, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Adial Pharmaceuticals based on analysis of Adial Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Adial Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Adial Pharmaceuticals's related companies.
Story Coverage note for Adial Pharmaceuticals
The number of cover stories for Adial Pharmaceuticals depends on current market conditions and Adial Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Adial Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Adial Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Adial Pharmaceuticals Short Properties
Adial Pharmaceuticals' future price predictability will typically decrease when Adial Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Adial Pharmaceuticals WT often depends not only on the future outlook of the potential Adial Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Adial Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 25 M | |
Cash And Short Term Investments | 4 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Adial Stock
If you are still planning to invest in Adial Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adial Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Stocks Directory Find actively traded stocks across global markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |